Hans Sollinger, MD, PhD
University of Wisconsin, Madison
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hans Sollinger, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01053221 · Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related TransplantationUniversity of Wisconsin, Madison · terminated · Kidney Transplantation · principal investigator
- Ph2NCT01035593 · Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal TransplantationPharming Technologies B.V. · withdrawn · Graft Rejection, Kidney Transplantation · principal investigator
- N/ANCT00579592 · Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal TransplanationUniversity of Wisconsin, Madison · terminated · Acute Rejection, Renal Transplantation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.